The risks of using unapproved gene symbols
- PMID: 34626580
- PMCID: PMC8546045
- DOI: 10.1016/j.ajhg.2021.09.004
The risks of using unapproved gene symbols
Abstract
The use of approved nomenclature in publications is vital to enable effective scientific communication and is particularly crucial when discussing genes of clinical relevance. Here, we discuss several examples of cases where the failure of researchers to use a HUGO Gene Nomenclature Committee (HGNC)-approved symbol in publications has led to confusion between unrelated human genes in the literature. We also inform authors of the steps they can take to ensure that they use approved nomenclature in their manuscripts and discuss how referencing HGNC IDs can remove ambiguity when referring to genes that have previously been published with confusing alias symbols.
Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
References
-
- Zegallai H.M., Hatch G.M. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets. Mol. Cell. Biochem. 2021;476:1605–1629. - PubMed
-
- Schier A.F., Neuhauss S.C., Harvey M., Malicki J., Solnica-Krezel L., Stainier D.Y., Zwartkruis F., Abdelilah S., Stemple D.L., Rangini Z. Mutations affecting the development of the embryonic zebrafish brain. Development. 1996;123:165–178. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
